Jupiter Life Line Hospitals Limited

BSE: JLHL543980ISIN INE682M01020

Healthcare
Hospital
BSE 1000

Share price

₹279.95+16.60 (+6.30%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

Splits and bonuses

24 Jul 2026 · Split 5:1 (₹10 → ₹2)

52W high: ₹337.90
52W low: ₹230.41
Off 52W high: -17.15%
1M return: +10.22%
3M return: -13.37%
6M return: +11.81%
1Y return: -9.74%
20D avg volume: 22,574
50 DMA: ₹268.82
200 DMA: ₹270.54

Key ratios Consolidated

Market cap: ₹9,178 Cr
Current price: ₹279.95
52W high / low: ₹337.90 / ₹230.41
Face value: ₹2.00
P/E: 49.57
P/B: 5.63
EPS (TTM): ₹5.65
Book value / share: ₹49.73
ROE: —
ROCE: 13.80%
Operating margin: —
Net margin: —
Debt / equity: 0.33
Net debt: ₹453.77 Cr
Interest cover: 9.12
Dividend yield: 0.36%
Dividend / share (TTM): ₹1.00
Payout: 17.70%
Cash conversion cycle: 4.4 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	456.50	410.98	387.84	365.37	393.63	347.62	326.74	320.64	322.58	287.12	290.49	272.61
	10.54	10.59	9.15	9.13	11.27	12.87	7.03	8.30	9.44	8.37	8.95	8.06
	467.04	421.57	396.99	374.50	404.90	360.49	333.77	328.94	332.02	295.50	299.44	280.67
	391.96	371.02	330.94	311.19	330.68	298.96	271.67	262.38	263.11	235.35	239.52	222.44
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—
	84.32	79.67	76.85	76.71	74.53	68.73	59.49	60.33	59.55	53.55	53.36	48.39
	81.33	74.45	67.72	63.65	63.25	59.44	53.80	55.54	53.89	51.27	51.46	50.09
	13.83	12.86	9.01	7.55	7.84	8.26	5.57	2.78	1.12	1.08	0.93	1.03
	28.48	26.44	23.26	21.70	21.46	21.20	17.62	13.97	14.40	11.00	10.39	10.65
	181.81	177.20	157.22	149.25	164.38	141.70	133.54	—	53.91	—	—	44.54
	75.08	50.55	66.05	63.31	74.22	61.53	62.09	66.56	68.91	60.14	59.92	58.23
	0.00	0.00	0.00	-6.40	0.00	0.00	0.00	0.00	0.00	0.00	2.28	-0.15
	75.08	50.55	66.05	56.91	74.22	61.53	62.09	66.56	68.91	60.14	62.20	58.08
	18.73	13.04	17.29	14.41	16.75	17.66	17.22	14.04	17.40	15.54	16.93	14.42
	56.36	37.51	48.76	42.50	57.48	43.88	44.87	52.51	51.51	44.60	45.27	43.67
	1.72	5.72	7.66	6.49	8.75	6.69	6.84	8.01	7.86	6.80	6.49	6.56
Key metrics
	117.39	89.85	98.32	86.16	103.52	90.99	85.28	83.31	84.43	72.22	73.52	69.76
	25.70%	21.90%	25.40%	23.60%	26.30%	26.20%	26.10%	26.00%	26.20%	25.20%	25.30%	25.60%
	12.30%	9.10%	12.60%	11.60%	14.60%	12.60%	13.70%	16.40%	16.00%	15.50%	15.60%	16.00%
	3.80%	—	3.50%	—	4.40%	—	3.90%	—	—	—	—	—
	16.00%	18.20%	18.70%	14.00%	22.00%	21.10%	12.50%	17.60%	—	—	—	—
	-1.90%	-14.50%	8.70%	-19.10%	11.60%	-1.60%	-0.90%	20.20%	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	1,621	1,500	1,262	1,070
	39.41	42.37	28.68	25.98
	1,660	1,542	1,290	1,095
	1,405	1,277	1,033	900.07
	0.00	0.00	0.00	—
	317.55	299.14	232.92	191.81
	287.15	256.32	214.50	189.94
	43.25	32.66	10.55	26.34
	99.88	87.64	56.98	42.38
	665.48	612.94	520.32	—
	254.99	265.32	257.70	195.41
	-6.40	0.00	0.00	0.00
	248.59	265.32	257.70	195.41
	63.47	66.25	64.20	18.80
	185.13	199.07	193.50	176.61
	21.59	29.59	29.47	28.65
Key metrics
	391.72	385.62	325.23	264.13
	24.17%	25.70%	25.80%	24.70%
	11.42%	13.30%	15.30%	16.50%
	—	13.80%	15.30%	—
	16.71%	18.90%	18.00%	—
	-6.85%	2.90%	9.60%	—
	—	-234.14	-67.43	—
	—	1.34	1.31	—
	—	0.33	0.24	—
	—	453.77	-42.60	—
	—	4.4	-10.7	—
Balance sheet
	—	2,383	1,905	—
	—	684.90	687.05	—
	—	54.76	368.32	—
	—	75.54	41.89	—
	—	38.34	24.10	—
	—	14.20	17.75	—
	—	1,376	972.85	—
	—	95.54	102.91	—
	—	226.57	152.43	—
	—	508.53	325.72	—
	—	7.63	3.97	—
	—	500.90	321.75	—
	—	1,544	1,356	—
Cash flow
	—	267.71	253.30	—
	—	-441.93	-208.62	—
	—	136.47	300.63	—
	—	501.85	320.73	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	364.60	328.49	312.42	291.40	315.82	277.94	273.91	269.13	273.10	239.41	245.31	230.38
	6.89	10.64	8.95	9.16	11.31	12.88	6.95	8.13	9.26	8.24	8.74	7.92
	371.49	339.13	321.37	300.56	327.12	290.82	280.87	277.26	282.36	247.65	254.05	238.30
	302.98	289.01	256.98	235.25	256.64	230.07	219.08	214.98	215.07	192.66	197.32	181.99
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—
	61.48	58.89	59.72	56.83	55.93	51.13	49.49	49.90	49.62	43.58	44.79	39.83
	62.78	56.95	51.74	48.27	48.45	47.39	44.14	45.92	44.66	42.50	42.53	40.94
	9.04	8.12	4.22	2.65	2.96	3.00	4.00	2.65	1.00	0.94	0.93	1.01
	23.46	21.57	18.47	16.82	16.68	16.67	13.38	10.64	10.41	7.98	7.47	7.65
	144.47	142.74	127.04	115.91	133.14	112.25	106.54	42.94	43.91	41.29	—	38.00
	68.51	50.11	64.39	65.31	70.48	60.75	61.78	62.28	67.29	54.99	56.73	56.31
	0.00	0.00	0.00	-5.54	0.00	0.00	0.00	—	—	—	2.28	-0.15
	68.51	50.11	64.39	59.76	70.48	60.75	61.78	62.28	67.29	54.99	59.01	56.16
	17.05	12.92	16.34	15.48	15.88	17.46	17.33	12.97	17.00	14.34	15.87	13.93
	51.45	37.19	48.05	44.28	54.60	43.29	44.45	49.31	50.30	40.65	43.15	42.23
	1.57	5.67	7.51	6.75	8.33	6.60	6.78	7.52	7.67	6.20	6.47	6.48
Key metrics
	101.01	79.80	87.08	79.23	90.12	80.42	79.16	75.57	78.70	63.91	67.41	64.82
	27.70%	24.30%	27.90%	27.20%	28.50%	28.90%	28.90%	28.10%	28.80%	26.70%	27.50%	28.10%
	14.10%	11.30%	15.40%	15.20%	17.30%	15.60%	16.20%	18.30%	18.40%	17.00%	17.60%	18.30%
	3.60%	—	3.50%	—	4.40%	—	4.10%	—	—	—	—	—
	15.40%	18.20%	14.10%	8.30%	15.60%	16.10%	11.70%	16.80%	—	—	—	—
	-5.80%	-14.10%	8.10%	-10.20%	8.50%	6.50%	3.00%	16.80%	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	1,297	1,198	1,060	910.63
	35.64	42.25	28.14	29.63
	1,333	1,240	1,088	940.26
	1,084	978.95	841.79	736.44
	0.00	0.00	0.00	—
	236.92	223.62	192.59	160.00
	219.74	195.85	177.22	158.61
	24.03	12.84	8.61	18.66
	80.32	68.63	42.41	30.52
	530.16	488.35	422.37	—
	248.32	260.93	246.34	203.82
	-5.54	0.00	0.00	—
	242.77	260.93	246.34	203.82
	61.79	65.16	61.64	51.87
	180.97	195.77	184.70	151.95
	21.50	29.19	28.17	24.89
Key metrics
	347.12	342.40	297.36	253.00
	26.77%	28.60%	28.10%	27.80%
	13.95%	16.30%	17.40%	16.70%
	—	13.90%	16.00%	—
	14.08%	13.00%	16.40%	—
	-5.57%	6.00%	21.60%	—
	—	-252.34	-60.53	—
	—	1.18	1.19	—
	—	0.16	0.05	—
	—	223.60	-292.41	—
	—	7.1	-9.4	—
Balance sheet
	—	2,160	1,710	—
	—	671.92	665.88	—
	—	37.43	367.41	—
	—	67.14	36.56	—
	—	28.51	18.17	—
	—	10.39	8.74	—
	—	1,115	708.87	—
	—	72.65	82.16	—
	—	185.03	121.57	—
	—	261.03	75.00	—
	—	2.62	0.75	—
	—	258.41	74.25	—
	—	1,608	1,423	—
Cash flow
	—	230.85	219.88	—
	—	-423.40	-173.29	—
	—	145.44	301.84	—
	—	483.19	280.41	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +14.08%
Profit YoY (TTM): -5.57%

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +16.71%
Profit YoY (TTM): -6.85%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 40.90%

Quarter	September 2026	June 2026
Promoter %	40.90%	40.90%

Holder	Type	Holding	Previous	Change
AJAY PRATAP THAKKER	Promoter	20.74%	20.74%	0.00%
WESTERN MEDICAL SOLUTIONS LLP	Promoter	8.70%	8.70%	0.00%
SBI HEALTHCARE OPPORTUNITIES FUND	Public	7.43%	7.77%	-0.34%
ANKIT AJAY THAKKER	Promoter	6.67%	6.67%	0.00%
HDFC MUTUAL FUND - HDFC MULTI CAP FUND	Public	3.46%	—	—
JM FINANCIAL PRODUCTS LIMITED	Public	3.42%	3.42%	0.00%
GOLDMAN SACHS FUNDS - GOLDMAN SACHS INDIA EQUITY P	Public	2.75%	—	—
MIHIR WIRE INDUSTRIES LLP	Public	2.15%	—	—
SBI LIFE INSURANCE CO. LTD	Public	2.10%	2.01%	+0.09%
GANDHI NEETA DEVANG	Promoter Group	2.10%	—	—
KIRTIKA AJAY THAKKER	Promoter Group	2.03%	2.03%	0.00%
DR NAVIN RAMJI DAVDA	Public	2.00%	2.00%	0.00%
J M FINANCIAL AND INVESTMENT CONSULTANCY SERVICESPRIVATE LIMITED	Public	1.91%	—	—
RAMAKANT JAGDISH TIBREWALA	Public	1.87%	1.87%	0.00%
BRIJESH RAMAKANT TIBREWALA	Public	1.80%	1.80%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Apollo Hospitals Enterprises Ltd.	1,23,324	8,577.00	56.78	19.50%	+19.24% TTM	+35.20% TTM	+9.78%
Max Healthcare Institute Limited	90,129	926.00	65.28	12.70%	+15.17% TTM	+1.73% TTM	-18.59%
Manipal Health Enterprises Limited	87,828	667.70	—	—	—	—	—
ASTER DM QUALITY CARE LIMITED	62,665	718.90	172.72	10.20%	+15.70% TTM	+3.89% TTM	+4.39%
Fortis Healthcare Ltd	59,710	790.90	55.79	12.00%	+17.50% TTM	+18.62% TTM	-22.35%
Narayana Hrudayalaya Limited	39,427	1,929.30	45.89	11.40%	+71.40% TTM	+1.61% TTM	+5.41%
Global Health Limited	37,682	1,401.45	61.46	15.00%	+26.18% TTM	+9.16% TTM	+12.21%
Krishna Institute of Medical Sciences Limited	31,074	739.85	159.85	8.20%	+30.90% TTM	-51.92% TTM	+3.15%
Dr. Agarwal's Health Care Limited	16,618	524.15	89.77	9.70%	—	—	+1.80%
Rainbow Children's Medicare Limited	12,990	1,278.95	43.51	16.80%	+22.83% TTM	+17.12% TTM	-8.02%
PARK MEDI WORLD LIMITED	9,958	230.55	—	18.10%	—	—	—
YATHARTH HOSPITAL & TRAUMA CARE SERVICES LIMITED	9,900	1,027.45	54.50	11.00%	+50.40% TTM	+19.12% TTM	+25.09%
HealthCare Global Enterprises Limited	9,286	621.95	279.19	6.90%	+13.77% TTM	-19.23% TTM	—
Jupiter Life Line Hospitals Limited	9,178	279.95	49.57	13.80%	+16.71% TTM	-6.85% TTM	-9.74%
Paras Healthcare Limited	8,135	751.85	—	—	—	—	—
Kovai Medical Center & Hospital Ltd S	6,561	5,996.35	25.97	20.60%	+14.96% TTM	+16.29% TTM	-1.95%
Artemis Medicare Services Limited	4,758	300.60	41.36	13.70%	+14.77% TTM	+21.46% TTM	+22.59%
Indraprastha Medical Corporation Lt S	3,092	337.25	16.09	30.70%	+10.72% TTM	+9.95% TTM	-44.21%
Dr.Agarwals Eye Hospital Ltd. S	2,616	5,413.80	34.33	16.10%	+20.01% TTM	+31.87% TTM	+2.39%
KMC Speciality Hospitals India Limited S	2,453	150.40	43.98	24.60%	+35.05% TTM	+137.83% TTM	+118.35%
Shalby Limited	1,336	123.70	35.06	7.90%	+7.27% TTM	+17,422.73% TTM	-49.15%
GUJARAT KIDNEY AND SUPER SPECIALITY LIMITED	1,260	159.75	75.29	8.60%	—	—	—
GPT Healthcare Limited S	1,152	140.45	24.38	16.40%	+18.07% TTM	-0.78% TTM	-5.48%
Rays of Belief Limited	528	252.45	—	—	—	—	—
ASARFI HOSPITAL LIMITED	347	176.40	—	18.40%	—	—	+22.97%

Some figures use IPO-document inputs. Growth periods are shown per value; FY means annual.

Filings & corporate actions

Recent announcements

Q2 FY27 Earnings Conference Call - Transcript29 Oct 2026 · Company Update / Earnings Call Transcript
Audio Link of Analyst/ Investor Conference Call for Q2 & H1 FY2726 Oct 2026 · Company Update / Analyst / Investor Meet
Intimation of Newspaper Publication for Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 202625 Oct 2026 · Company Update / Newspaper Publication
Investor Presentation for the quarter and half year ended September 30, 202623 Oct 2026 · Company Update / Investor Presentation
Sale agreement for the acquisition of land, South Pune.23 Oct 2026 · Company Update / General
Incorporation of a wholly owned subsidiary of the Company23 Oct 2026 · Company Update / Acquisition
Outcome of the Board Meeting held on Friday, October 23, 202623 Oct 2026 · Result / Financial Results
Outcome of the Board Meeting held on Friday, October 23, 202623 Oct 2026 · Board Meeting / Outcome of Board Meeting
Jupiter Life Line Hospitals Limited ('JLHL/Company') has entered into hypothecation agreement with HDFC Bank Limited executed on 18/10/2026 for financing the capital expenditure requirement ....19 Oct 2026 · Company Update / General
Intimation of Earnings Conference Call - Q2 & H1 FY 278 Oct 2026 · Company Update / Analyst / Investor Meet
Jupiter Life Line Hospitals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2026 ,inter alia, to consider and approve Unaudited Financial ....8 Oct 2026 · Board Meeting / Board Meeting
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.7 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation of Closure of Trading Window.25 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure requirements) Regulations 2015.15 Sep 2026 · Company Update / Analyst / Investor Meet
Q1 FY27 Earnings Conference Call - Transcript7 Aug 2026 · Company Update / Earnings Call Transcript
Intimation of Newspaper Publication for Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30,2026.3 Aug 2026 · Company Update / Newspaper Publication
Audio Link of Analyst/ Investor Conference Call for Q1 FY273 Aug 2026 · Company Update / Analyst / Investor Meet
Intimation under Regulation 30(5) of the Listing Regulation31 Jul 2026 · Company Update / General
Investor Presentation for the quarter ended June 30, 202631 Jul 2026 · Company Update / Investor Presentation
Acquistion of shares31 Jul 2026 · Company Update / Acquisition
Change in Managment31 Jul 2026 · Company Update / Change in Management
Outcome of Board Meeting dated July 31, 202631 Jul 2026 · Result / Financial Results
Outcome of Board Meeting dated July 31, 202631 Jul 2026 · Board Meeting / Outcome of Board Meeting
The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd30 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd29 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Intimation of Earnings Conference Call - Q1 FY 2727 Jul 2026 · Company Update / Analyst / Investor Meet
Jupiter Life Line Hospitals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 ,inter alia, to consider and approve Unaudited Financial ....27 Jul 2026 · Board Meeting / Board Meeting
Voting Results and Scrutinizer's Report of the 24th Annual General Meeting of the Company17 Jul 2026 · AGM/EGM / AGM
We refer to our intimation dated May 15, 2026, and June 22, 2026, regarding the sub-division/split of the existing equity shares of the Company. In this regard, we wish to inform you that, ....17 Jul 2026 · Corp. Action / Record Date
Proceedings of the 24th Annual General Meeting of the Company (for detailed proceedings please refer the attached pdf)17 Jul 2026 · AGM/EGM / AGM
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 20266 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Letter to Shareholders- Weblink of AGM Notice and Annual Report29 Jun 2026 · Company Update / General
Intimation of Newspaper Advertisement for the 24th Annual General Meeting of the Company to be held on Friday, July 17, 2026, through Video Conference (VC') /Other Audio-Visual Means ('OAVM').25 Jun 2026 · Company Update / Newspaper Publication
Intimation of Closure of Trading Window.25 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Annual Report 2025-2624 Jun 2026 · Others / Reg. 34 (1) Annual Report
Annual Report 2025-2624 Jun 2026 · Others / Reg. 34 (1) Annual Report
Business Responsibility and Sustainability Report for the Financial year 2025-26.22 Jun 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Notice of the 24th Annual General Meeting of the Company will be held on Friday, July 17, 2026 at 11:00 A.M. IST through Video Conferencing/ Other Audio Visual Means ('VC/ OAVM')22 Jun 2026 · AGM/EGM / AGM
Intimation of Newspaper Publication of the 24th Annual General Meeting of the Company to be held on Friday, July 17, 2026 through Video Conference ('VC') /Other Audio-Visual Means ('OAVM').19 Jun 2026 · Company Update / Newspaper Publication
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure requirements) Regulations 2015.3 Jun 2026 · Company Update / Analyst / Investor Meet

Corporate actions

Purpose	Ex date	Record date	Payment date
Stock Split From Rs.10/- to Rs.2/-	24 Jul 2026	24 Jul 2026	—
Interim Dividend - Rs. - 1.0000	22 May 2026	22 May 2026	—
Final Dividend - Rs. - 1.0000	4 Jul 2025	4 Jul 2025	—
Final Dividend - Rs. - 1.0000	2 Aug 2024	2 Aug 2024	—

Board meetings

23 Oct 2026 Board Meeting - Financial Results
31 Jul 2026 Board Meeting - Financial Results